How to overcome resistance to one group of breast cancer drugs

Jun 08, 2010

A team of researchers, led by Carlos Arteaga, at Vanderbilt University Medical Center, Nashville, has identified a mechanism by which human breast cancer cells can develop resistance to one group of drugs used to treat breast cancer, suggesting new approaches to treating the disease.

A large proportion of breast cancers express the molecule to which the sex hormone estrogen binds and show a degree of dependence on the hormone for growth. Patients with such tumors are usually treated with drugs known as endocrine therapies that interfere with estrogen signaling to the tumor cell. However, some cancers develop resistance to endocrine therapies after initially responding.

To define mechanisms underlying the development of resistance to endocrine therapies, Arteaga and colleagues analyzed molecular changes in human cell lines subject to long-term estrogen deprivation (a condition that mimics an endocrine therapy regimen). They found evidence of PI3K signaling pathway activation, and cells treated with a PI3K inhibitor died.

As a breast tumor protein signature of PI3K pathway activation was found to predict poor outcome after endocrine therapy in patients, the authors suggest that combining an endocrine therapy with a PI3K pathway inhibitor might help prevent the development of resistance to endocrine therapies in patients with breast cancer.

Explore further: Generation of tanners see spike in deadly melanoma

More information: www.jci.org/articles/view/4168… 9e3ff18962ef2def510c

Provided by Journal of Clinical Investigation

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Generation of tanners see spike in deadly melanoma

11 hours ago

(AP)—Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.

Penn team makes cancer glow to improve surgical outcomes

11 hours ago

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

Cancer: Tumors absorb sugar for mobility

23 hours ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

User comments : 0